Bayern Munich Await Updates on Jamal Musiala After Collapse

MUNICH — Bayern Munich were left with more questions than answers on Sunday after Jamal Musiala collapsed late in a preseason friendly against RB Leipzig, with the club declining to issue any medical update on the midfielder.

The 23-year-old went down suddenly shortly before the final whistle on Saturday, shocking teammates and silencing the stadium. Medical staff sprinted onto the pitch and formed a ring around him as they began treatment.

Tension eased only when one member of the medical team turned to the touchline and raised a thumbs up, a small but crucial signal that Musiala was at least responsive.

According to German agency DPA, Musiala eventually got back to his feet and was able to walk off without assistance. He made his way down the steps into the players’ tunnel on his own, though he still looked visibly dazed.

“The main thing is that he's OK,” a Bayern board member for sport said several hours after the incident.

The club, however, did not disclose any diagnosis, give details on his condition, or indicate what might have triggered the collapse.

The conditions in Munich were punishing. Temperatures climbed above 30 degrees Celsius (86 Fahrenheit) during the game, and the heat is being considered as a possible factor.

The Associated Press has requested further information from Bayern on Musiala’s status, but as of Sunday there had been no response.

Musiala’s scare comes less than a year after a major setback in his career. He broke his leg last summer in Bayern’s Club World Cup match against Paris Saint-Germain and only returned to Bundesliga action at the start of 2026.

Once back, he hit full stride quickly enough to become a key figure for Germany at the 2026 World Cup, where Julian Nagelsmann’s team suffered a shock exit in the round of 32 against Paraguay.

Now Bayern and Germany alike can only wait and hope the latest incident proves to be nothing more than a frightening pause in a career that has already endured more than its share of early tests.